AGNG

Aging Population ETF

Fund Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

Fund Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Why AGNG?

High Growth Potential

AGNG enables investors to access high growth potential through companies at the leading edge of a long-term, structural demographic trend affecting multiple sectors of the global economy.

Unconstrained Approach

AGNG's composition transcends classic sector, industry, and geographic classifications by tracking an emerging theme.

ETF Efficiency

In a single trade, AGNG delivers access to dozens of companies with high exposure to the Longevity theme.

Fund Details As of 05/12/21

Key Facts

Ticker	AGNG
Inception Date	05/09/16
CUSIP	37954Y772
ISIN	US37954Y7720
Bloomberg Index Ticker	ILNGRNT
Primary Exchange	Nasdaq
Number of Holdings	99

Stats & Fees

Net Assets	$40,698,131
Net Asset Value (NAV)	$28.07
Shares Outstanding	1,450,000
Total Expense Ratio	0.50%

Distributions

30-Day SEC Yield	0.53%
Distribution Frequency	Semi-Annually

Fund Documents

Fund Research

Fund Prices As of 05/12/21

NAV	$28.07	Daily Change	-$0.34	-1.20%
Market Price	$28.03	Daily Change	-$0.42	-1.47%
30-Day Median Bid-Ask Spread	0.31%

As of recent (03/31/21) As of recent (03/31/21)	Fund NAV	Market Price	Index
1 Year	37.23%	37.70%	37.64%
3 Years	12.81%	12.79%	13.07%
Since Inception	13.85%	14.40%	14.16%
1 Year	28.96%	29.18%	29.36%
3 Years	15.04%	14.95%	15.31%
Since Inception	14.66%	15.15%	14.98%
Year-to-Date	-1.25%	-0.61%	-1.22%
1 Month	-0.36%	-0.22%	-0.37%
3 Months	-1.25%	-0.61%	-1.22%
Since Inception	88.63%	93.16%	91.25%
Year-to-Date	3.39%	3.80%	3.48%
1 Month	4.70%	4.43%	4.76%
3 Months	3.06%	2.77%	3.12%
Since Inception	97.49%	101.72%	100.35%

Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance of the Fund, when observed, is unusual and investors should not expect such performance to be repeated.

Fund Characteristics As of 05/11/21

Return on Equity	14.40%
Weighted Avg. Market Cap	78,705 M
	2020	2021
Price-to-earnings	32.98	29.06
Price-to-book value	4.39	4.02

Source: AltaVista Research, LLC

Fund Risk Stats As of 05/11/21

Versus	Beta
S&P 500	0.83
MSCI EAFE	0.78
MSCI Emg. Mkts	0.63
Standard Deviation	18.30%

Source: AltaVista Research, LLC

Sector Breakdown As of 04/30/21

% of Net Assets
	Health Care	93.4
	Real Estate	5.2
	Information Technology	0.7
	Communication Services	0.4
	Industrials	0.3

Source: AltaVista Research, LLC

Country Breakdown As of 04/30/21

% of Net Assets
	United States	57.3
	Switzerland	7.5
	Japan	6.6
	Denmark	5.9
	Britain	5.7
	China	5.6
	Ireland	3.4
	South Korea	1.9
	Germany	1.4
	Belgium	1.3
	France	0.8
	Other/Cash	2.6

Source: AltaVista Research, LLC

Net Assets (%)	Ticker	Name	SEDOL	Market Price ($)	Shares Held	Market Value ($)
3.41	NOVOB DC	NOVO NORDISK A/S-B	BHC8X90	77.76	17,849	1,387,994.68
3.35	AZN	ASTRAZENECA PLC-SPONS ADR	2989044	54.50	24,979	1,361,355.50
3.29	ABBV	ABBVIE INC	B92SR70	114.96	11,654	1,339,743.84
3.24	BSX	BOSTON SCIENTIFIC CORP	2113434	41.35	31,930	1,320,305.50
3.23	REGN	REGENERON PHARMACEUTICALS	2730190	507.14	2,595	1,316,028.30
3.20	LLY	ELI LILLY & CO	2516152	192.35	6,771	1,302,401.85
3.17	BMY	BRISTOL-MYERS SQUIBB CO	2126335	64.53	19,970	1,288,664.10
3.16	EW	EDWARDS LIFESCIENCES CORP	2567116	87.47	14,690	1,284,934.30
3.14	JNJ	JOHNSON & JOHNSON	2475833	168.20	7,588	1,276,301.60
3.10	MDT	MEDTRONIC PLC	BTN1Y11	123.12	10,248	1,261,733.76
3.09	AMGN	AMGEN INC	2023607	250.83	5,008	1,256,156.64
3.09	RO SW	ROCHE HOLDING AG-BR	7108918	354.29	3,545	1,255,971.83
2.98	SYK	STRYKER CORP	2853688	244.76	4,948	1,211,072.48
2.77	4519 JP	CHUGAI PHARMA CO	6196408	36.45	30,931	1,127,514.49
2.48	BIIB	BIOGEN INC	2455965	274.02	3,682	1,008,941.64
2.03	ZBH	ZIMMER BIOMET HO	2783815	163.77	5,038	825,073.26
1.99	ALC SW	ALCON INC	BJT1GR5	67.03	12,084	809,987.65
1.92	DXCM	DEXCOM INC	B0796X4	333.48	2,338	779,676.24
1.91	068270 KS	CELLTRION INC	B0C5YV1	233.41	3,329	777,008.40
1.76	WELL	WELLTOWER INC	BYVYHH4	71.04	10,103	717,717.12
1.71	BGNE	BEIGENE LTD-ADR	BYYWPW6	312.65	2,222	694,708.30
1.69	4503 JP	ASTELLAS PHARMA INC	6985383	15.21	45,100	685,932.34
1.67	4543 JP	TERUMO CORP	6885074	36.82	18,447	679,186.92
1.56	SGEN	SEAGEN INC	BLPK4D2	144.77	4,395	636,264.15
1.39	GMAB DC	GENMAB A/S	4595739	362.30	1,561	565,557.67
1.39	FME GR	FRESENIUS MEDICA	5129074	79.41	7,110	564,616.89
1.36	STMN SW	STRAUMANN HOLDING AG-REG	7156832	1,461.74	379	553,998.46
1.35	3692 HK	HANSOH PHARMACEU	BJYKB72	3.90	141,000	549,217.43
1.17	VTR	VENTAS INC	2927925	52.18	9,102	474,942.36
1.09	SN/ LN	SMITH & NEPHEW PLC	0922320	21.27	20,839	443,148.59
1.08	NVCR	NOVOCURE LTD	BYSS4X4	179.83	2,437	438,245.71
1.08	TFX	TELEFLEX INC	2881407	385.62	1,136	438,064.32
1.06	SOON SW	SONOVA HOLDING AG-REG	7156036	280.46	1,538	431,354.13
1.06	UCB BB	UCB SA	5596991	93.49	4,613	431,279.76
1.06	INCY	INCYTE CORP	2471950	82.37	5,214	429,477.18
0.95	EXAS	EXACT SCIENCES CORP	2719951	96.11	4,024	386,746.64
0.87	PODD	INSULET CORP	B1XGNW4	225.52	1,572	354,517.44
0.80	DVA	DAVITA INC	2898087	122.78	2,634	323,402.52
0.78	853 HK	MICROPORT SCIENTIFIC CORP	B676TW7	7.41	43,000	318,649.76
0.72	ABMD	ABIOMED INC	2003698	272.25	1,072	291,852.00
0.68	DEMANT DC	DEMANT A/S	BZ01RF1	48.51	5,721	277,511.89
0.64	GN DC	GN STORE NORD A/S	4501093	77.15	3,382	260,935.43
0.63	COH AU	COCHLEAR LTD	6211798	165.03	1,555	256,618.32
0.53	AMP IM	AMPLIFON SPA	B14NJ71	40.35	5,379	217,020.36
0.51	UTHR	UNITED THERAPEUTICS CORP	2430412	195.49	1,051	205,459.99
0.50	NBIX	NEUROCRINE BIOSC	2623911	92.15	2,217	204,296.55
0.50	AMED	AMEDISYS INC	2024332	260.00	780	202,800.00
0.47	ORP FP	ORPEA	7339451	125.17	1,524	190,755.35
0.47	OHI	OMEGA HEALTHCARE	2043274	34.86	5,467	190,579.62
0.45	EXEL	EXELIXIS INC	2576941	25.16	7,348	184,875.68
0.36	1858 HK	BEIJING CHUNLI-H	BVVPXP6	3.01	48,500	146,136.07
0.36	DNLI	DENALI THERAPEUTICS INC	BD2B4V0	51.17	2,846	145,629.82
0.36	INGN	INOGEN INC	BJSVLL5	63.18	2,293	144,871.74
0.36	HALO	HALOZYME THERAPEUTICS INC	2975098	42.48	3,401	144,474.48
0.35	LHCG	LHC GROUP INC	B06DT50	190.32	750	142,740.00
0.33	1302 HK	LIFETECH SCIENTIFIC CORP	BV9FKS0	0.55	244,000	135,415.04
0.33	FGEN	FIBROGEN INC	BSDRYR8	21.13	6,381	134,830.53
0.33	1789 HK	AK MEDICAL HOLDINGS LTD	BFD6SZ0	1.50	88,000	132,123.80
0.32	8086 JP	NIPRO CORP	6641599	12.06	10,914	131,616.60
0.32	2186 HK	LUYE PHARMA GROUP LTD	BNQ4GF3	0.61	213,147	130,368.49
0.32	CSH-U CN	CHARTWELL RETIRE	B8S8C94	10.47	12,263	128,353.17
0.31	ACAD	ACADIA PHARMACEU	2713317	21.83	5,804	126,701.32
0.31	RDUS	RADIUS HEALTH INC	BM68KK1	20.89	6,034	126,050.26
0.31	RYM NZ	RYMAN HEALTHCARE LTD	6161525	10.73	11,717	125,692.72
0.31	LIVN	LIVANOVA PLC	BYMT0J1	83.47	1,501	125,288.47
0.31	BPMC	BLUEPRINT MEDICINES CORP	BWY52P3	91.65	1,359	124,552.35
0.31	BLUE	BLUEBIRD BIO INC	BBFL7S1	29.85	4,158	124,116.30
0.30	AGIO	AGIOS PHARMACEUTICALS INC	BCBVTX1	54.32	2,269	123,252.08
0.30	KORI FP	KORIAN	B1HKRM0	38.86	3,171	123,226.68
0.30	AED BB	AEDIFICA	B1G5XP1	122.81	1,003	123,181.18
0.30	EPZM	EPIZYME INC	B9Z1QZ7	8.55	14,243	121,777.65
0.30	OMER	OMEROS CORP	B4NB858	17.85	6,779	121,005.15
0.30	HRTX	HERON THERAPEUTICS INC	BJ0XLZ3	17.41	6,950	120,999.50
0.30	TCMD	TACTILE SYSTEMS	BZB1XF2	52.11	2,316	120,686.76
0.30	2500 HK	VENUS MEDTECH -H	BL6V047	8.55	14,100	120,555.49
0.30	BKD	BROOKDALE SR	B0PZN33	6.99	17,242	120,521.58
0.29	NUVA	NUVASIVE INC	B00GJC2	67.40	1,778	119,837.20
0.29	MMSI	MERIT MEDICAL SYSTEMS INC	2580555	59.10	2,005	118,495.50
0.29	ITGR	INTEGER HOLDINGS CORP	BD06LM7	89.73	1,319	118,353.87
0.29	EKTAB SS	ELEKTA AB-B SHS	B0M42T2	13.38	8,761	117,241.12
0.29	SILK	SILK ROAD MEDICAL INC	BGHVXJ7	48.27	2,412	116,427.24
0.28	NHC	NATIONAL HEALTHCARE CORP	2139731	70.51	1,585	111,758.35
0.27	MNKD	MANNKIND CORP	BF081J4	4.02	27,770	111,635.40
0.27	ANGO	ANGIODYNAMICS INC	B00CR04	22.39	4,964	111,143.96
0.27	AERI	AERIE PHARMACEUTICALS INC	BFRTDG1	17.59	6,318	111,133.62
0.27	ARNA	ARENA PHARMACEUTICALS INC	BF3N4P3	61.23	1,805	110,520.15
0.27	SBRA	SABRA HEALTH CAR	B5NLBP6	16.94	6,488	109,906.72
0.27	4547 JP	KISSEI PHARM CO	6494061	19.12	5,640	107,823.91
0.26	LTC	LTC PROPERTIES INC	2498788	39.10	2,750	107,525.00
0.26	GKOS	GLAUKOS CORP	BYMWL19	75.76	1,414	107,124.64
0.26	ENSG	ENSIGN GROUP INC/THE	B1YWPP8	81.75	1,296	105,948.00
0.26	NHI	NATL HEALTH INVESTORS INC	2626125	65.65	1,608	105,565.20
0.26	TBPH	THERAVANCE BIOPHARMA INC	BMNDK09	18.87	5,510	103,973.70
0.25	PHM SM	PHARMA MAR SA	BMW2GT8	99.22	1,037	102,887.27
0.25	ALEC	ALECTOR INC	BJ4LDC4	16.79	6,105	102,502.95
0.23	ATEC	ALPHATEC HOLDINGS INC	BD60BG7	13.75	6,902	94,902.50
0.22	PNTG	PENNANT GROUP INC/THE	BKTC976	32.96	2,727	89,881.92
0.22	DHC	DIVERSIFIED HEAL	BKRN595	3.56	24,906	88,665.36
0.21	AMRN	AMARIN CORP PLC -ADR	2301938	4.35	19,927	86,682.45
0.21		CASH		1.02	81,723	83,428.79

Holdings are subject to change.

Latest Premium / Discount As of 05/12/21

NAV	$28.07
Market Price	$28.03
Premium / (Discount)	($0.04)

Current View 2021 Q2 As of 05/12/21

Days at Premium	22
Days at NAV	0
Days at Discount	7
Greatest Premium	0.36%
Greatest Discount	-0.23%

Daily Premium / Discount History As of 05/12/21

Hover over the chart points for details

View Chart Explanation

Download Chart Data (.CSV)

How can the Fund trade at a premium/discount to its NAV?

The primary explanation is that timing discrepancies can arise between the NAV and the trading price of the Fund. Since shares of the Fund trade on the open market, prices are affected by the constant flow of information received by investors, corporations and financial institutions. Depending on how this changing information affects investor sentiment, shares of the Fund may deviate slightly from the value of the Fund's underlying assets. The NAV of the Fund is only calculated once a day (normally at 4:00 p.m. eastern time). As a result, shareholders may pay more than NAV when they buy Fund shares and receive less than NAV when they sell those shares, because shares are purchased and sold at current market prices. However, due to the creation and redemption process that is unique to ETFs, market makers are able to minimize these deviations from NAV by taking advantage of arbitrage opportunities.

What causes these time discrepancies?

Close of Trading Times. Although both the NAV and the daily market price of the Fund are generally calculated based on prices at the closing time of the exchange (generally 4:00 p.m. eastern time), slight differences in this timing may cause discrepancies.

Time of Last Trade. Trading of Global X funds generally takes place during normal trading hours (9:30 a.m. to 4:00 p.m. eastern time). However, it is important to note that the last trade - from which the closing price is determined - may not occur at exactly 4:00 p.m. eastern time. Therefore, changing market sentiment during the time difference may cause the NAV to deviate from the closing price.

International Holdings. The premiums and discounts for funds with significant holdings in international markets may be less accurate due to the different closing times of various international markets. Because the Funds trade during U.S. market hours while the underlying securities may not, the time lapse between the markets can result in differences between the NAV and the trading price.

Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.

AGNG

Aging Population ETF

Fund Summary

Fund Objective

Why AGNG?

High Growth Potential

Unconstrained Approach

ETF Efficiency

Fund Details As of 05/12/21

Key Facts

Stats & Fees

Distributions

Fund Documents

Fund Research

Fund Prices As of 05/12/21

Performance History

Fund Characteristics As of 05/11/21

Fund Risk Stats As of 05/11/21

Sector Breakdown As of 04/30/21

Country Breakdown As of 04/30/21

Top Holdings As of 05/12/21